arrow_back Back to App

Medicare: Multi-Cancer Early Detection Coverage

This bill aims to expand Medicare coverage to include multi-cancer early detection screening tests. This will give seniors access to innovative blood tests that can detect cancer at an early stage, increasing the chances of effective treatment and reducing healthcare costs. It's a significant step towards improving the health and financial security of Medicare beneficiaries.
Key points
Medicare will cover new blood tests that detect multiple types of cancer simultaneously.
Early cancer detection can lead to less invasive treatments and lower costs.
Tests will be available once every 11 months, after FDA approval.
The bill does not affect existing coverage for other cancer screenings like mammograms or colonoscopies.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2407
Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
Process start date: 2023-03-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2407.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-30.

What are the main provisions?

Key points include:

  • Medicare will cover new blood tests that detect multiple types of cancer simultaneously.
  • Early cancer detection can lead to less invasive treatments and lower costs.
  • Tests will be available once every 11 months, after FDA approval.
  • The bill does not affect existing coverage for other cancer screenings like mammograms or colonoscopies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Arrington, Jodey C. [R-TX-19].

What is the latest detailed status?

The latest detailed status is: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-893, Part I.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health